Conference abstractPublished 22 Oct 2018

Comparison of the outcomes of CABG vs PCI procedures in patients with poor left ventricular function (ejection fraction <30%): A propensity-matched analysis

Authors: Shaneel Shah

Bristol Heart Institute, UK

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: Existing evidence comparing the outcomes of coronary artery bypass graft surgery (CABG) vs. percutaneous coronary intervention (PCI) in patients with poor left ventricular function (LVF) is sparse and flawed. This is largely due to patients with poor LVF being underrepresented in major research trials and the out-dated nature of some studies which do not consider drug-eluting stent (DES) PCI. Methodology: Following strict inclusion criteria 717 patients who underwent revascularisation by CABG or PCI between 2002 and 2015 were enrolled. 100% of the patients had poor LVF (defined by ejection fraction <30%). By employing a propensity score analysis, 186 suitable matches (93 CABG, 93 PCI) were identified. Several outcomes were evaluated, in the matched population, using data extracted from national registry databases. Results: CABG patients required a longer length of hospital stay post-revascularisation compared to PCI, 8.91±1.38 and 4.96±1.38 days respectively (p<0.0001). Cox-regression proportional-hazards analysis found that PCI had a higher adjusted 5-year mortality rate (HR 1.752, 95% CI 0.998-3.078, p=0.05). This trend was consistent amongst urgent cases of revascularization, patients with 3 or more vessels with coronary artery disease, and cases where complete revascularization was achieved. Sub-analysis found the cumulative 5-year survival distribution for PCI with DES to be significantly higher than PCI without DES, but still lower than CABG (log-rank p=0.037; CABG 67.6±5.3%, PCI with DES 54.6±3.3%. PCI without DES 46.2±4.7%). Conclusions: Despite a longer length of hospital stay, CABG patients experience a greater post-procedural survival benefit compared to PCI patients. We have demonstrated this at 30 days, 90 days, 1 year, 3 years and 5 years following revascularisation. At present, CABG remains a superior revascularization modality to PCI in patients with poor LVF.

Subjects

Cardiology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Longdom does not store it.

Try:

More from this journal

The newest in Clinical and Experimental Cardiology.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical and Experimental Cardiology
  • SubjectCardiology
  • BylineArticles whose byline prints “Shaneel Shah”